Search research articles
Contact Us
Filters
Showing results (211-220 of 458) with videos related to
Page
of 46
Sort By:
Communications Biology
|
March 2, 2023
PARP1 allows proper telomere replication through TRF1 poly (ADP-ribosyl)ation and helicase recruitment
C Maresca, A Dello Stritto, C D'Angelo, et al.
Current Cancer Drug Targets
|
May 14, 2010
Pharmacological inhibition of poly(ADP-ribose) polymerase (PARP) activity in PARP-1 silenced tumour cells increases chemosensitivity to temozolomide and to a N3-adenine selective methylating agent
L Tentori, A Muzi, A S Dorio, et al.
The American Journal of Medicine
|
October 1, 1981
Prevention of calcium nephrolithiasis with low-dose thiazide, amiloride and allopurinol
G Maschio, N Tessitore, A D'Angelo, et al.
Oncogene
|
August 31, 2010
PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy
E Salvati, M Scarsella, M Porru, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
February 12, 2025
The dual role of VEGF-A in a complex in vitro model of oxaliplatin-induced neurotoxicity: Pain-related and neuroprotective effects
A Toti, E Lucarini, V Ferrara, et al.
Infection Prevention in Practice
|
August 9, 2021
Infection prevention in endoscopy practice: comparative evaluation of re-usable vs single-use endoscopic valves
L Pasquale, A Maurano, G Cengia, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
September 28, 2011
Chagas disease in Italy: breaking an epidemiological silence
A Angheben, M Anselmi, F Gobbi, et al.
United European Gastroenterology Journal
|
August 19, 2016
Predictive value of the Diverticular Inflammation and Complication Assessment (DICA) endoscopic classification on the outcome of diverticular disease of the colon: An international study
Antonio Tursi, Giovanni Brandimarte, Francesco Di Mario, et al.
European Review for Medical and Pharmacological Sciences
|
March 4, 2021
Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn's disease: results from a large Italian cohort study
A Tursi, G Mocci, A Cuomo, et al.
Physical Review Letters
|
April 3, 2012
Search for lepton number violating decays B+ → π- μ+ μ+ and B+ → K- μ+ μ+
R Aaij, C Abellan Beteta, B Adeva, et al.
Page
of 46
Search research articles
Search
Showing results (211-220 of 458) with videos related to
Sort By:
Page
of 46
Communications Biology
|
March 2, 2023
PARP1 allows proper telomere replication through TRF1 poly (ADP-ribosyl)ation and helicase recruitment
C Maresca, A Dello Stritto, C D'Angelo, et al.
Current Cancer Drug Targets
|
May 14, 2010
Pharmacological inhibition of poly(ADP-ribose) polymerase (PARP) activity in PARP-1 silenced tumour cells increases chemosensitivity to temozolomide and to a N3-adenine selective methylating agent
L Tentori, A Muzi, A S Dorio, et al.
The American Journal of Medicine
|
October 1, 1981
Prevention of calcium nephrolithiasis with low-dose thiazide, amiloride and allopurinol
G Maschio, N Tessitore, A D'Angelo, et al.
Oncogene
|
August 31, 2010
PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy
E Salvati, M Scarsella, M Porru, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
February 12, 2025
The dual role of VEGF-A in a complex in vitro model of oxaliplatin-induced neurotoxicity: Pain-related and neuroprotective effects
A Toti, E Lucarini, V Ferrara, et al.
Infection Prevention in Practice
|
August 9, 2021
Infection prevention in endoscopy practice: comparative evaluation of re-usable vs single-use endoscopic valves
L Pasquale, A Maurano, G Cengia, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
September 28, 2011
Chagas disease in Italy: breaking an epidemiological silence
A Angheben, M Anselmi, F Gobbi, et al.
United European Gastroenterology Journal
|
August 19, 2016
Predictive value of the Diverticular Inflammation and Complication Assessment (DICA) endoscopic classification on the outcome of diverticular disease of the colon: An international study
Antonio Tursi, Giovanni Brandimarte, Francesco Di Mario, et al.
European Review for Medical and Pharmacological Sciences
|
March 4, 2021
Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn's disease: results from a large Italian cohort study
A Tursi, G Mocci, A Cuomo, et al.
Physical Review Letters
|
April 3, 2012
Search for lepton number violating decays B+ → π- μ+ μ+ and B+ → K- μ+ μ+
R Aaij, C Abellan Beteta, B Adeva, et al.
Page
of 46